Abstract:Objectives Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. Study Design The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Results Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. Conclusions IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP. Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP.

Hydroxychloroquine Decreases the Upregulated Frequencies of Tregs in Patients with Oral Lichen Planus

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Glycyrrhizin Alleviates the Toxicity of Hydroxychloroquine in Treating Oral Lichen Planus by Occupying Heat Shock Protein 90 Alpha

Hydroxychloroquine is Effective in Oral Lichen Planus: A Multicenter, Randomized, Controlled Trial.

Significance of regulatory T cells in the peripheral blood of oral lichen planus patients

The Activation of NF-κB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus

TLR4-induced B7-H1 on Keratinocytes Negatively Regulates CD4+ T Cells and CD8+ T Cells Responses in Oral Lichen Planus.

Increasing CCL5/CCR5 on CD4+ T Cells in Peripheral Blood of Oral Lichen Planus

Expression of Foxp3 + regulatory T cells in oral lichen planus

Declined Htert Expression of Peripheral Blood Cd4(+) T Cells in Oral Lichen Planus Correlated with Clinical Parameter

Overexpressed Interleukin-6 Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus: an in Vitro Study

Increased circulating CXCR5 + CD4 + T follicular helper-like cells in oral lichen planus.

Reveals of quercetin’s therapeutic effects on oral lichen planus based on network pharmacology approach and experimental validation

Effect of Antimalarial Drug Hydroxychloroquine in Treating Erosive Oral Lichen Planus

Possible Alternative Therapies for Oral Lichen Planus Cases Refractory to Steroid Therapies

Increased Infiltration of CD11 C+/cd123+ Dendritic Cell Subsets and Upregulation of TLR/IFN-α Signaling Participate in Pathogenesis of Oral Lichen Planus.

Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus

Foxp3 gene expression in oral lichen planus: a clinicopathological study.

Oral Lichen Planus May Enhance the Expression of Th17-Associated Cytokines in Local Lesions of Chronic Periodontitis

Efficacy of antimalarials in oral lichen planus: A systematic review

Expression of T-bet and GATA-3 in Peripheral Blood Mononuclear Cells of Patients with Oral Lichen Planus.